
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Chongqing University Cancer Hospital"
Count: 51
Selected: 0
NCT ID | Title |
---|
NCT05548348 | First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon Mutation | ||
NCT04555226 | The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103) | ||
NCT06026995 | Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells | ||
NCT04542356 | Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer | ||
NCT05378087 | Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer | ||
NCT05304741 | The Culture of Advanced/Recurrent/Metastatic Colorectal Cancer Organoids and Drug Screening | ||
NCT05290961 | The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening | ||
NCT04768270 | The Culture of Ovarian Cancer Organoids and Drug Screening | ||
NCT05213884 | The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC | ||
NCT04830267 | The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M HNSCC | ||
NCT05401175 | Hematopoietic Stem Cell-containing Autologous Blood Transfusion for Bone Marrow Protection in Patients With Cervical Cancer | ||
NCT04409860 | The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer | ||
NCT05799469 | Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer | ||
NCT05793749 | Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy | ||
NCT05786989 | Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma | ||
NCT05779111 | A Retrospective Analysis: Whether Five Factors Affect PFS in Patients With Locally Advanced Cervical Cancer | ||
NCT05776407 | Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma | ||
NCT05749887 | The Efficacy of Salvage Surgery in Patients With Residual Tumor After Concurrent Chemoradiation for Locally Advanced Cervical Cancer. | ||
NCT05717751 | Predictors of Para-aortic Lymph Node Metastasis of Cervical Cancer | ||
NCT05687851 | Study Of Candonilimab Combined With Radiotherapy In The Treatment of Locally Advanced Cervical Cancer | ||
NCT05551208 | Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi | ||
NCT05401162 | Chemotherapy Supported by Autologous Hematopoietic Stem Cells | ||
NCT04905550 | Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC | ||
NCT04395612 | Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer | ||
NCT04588090 | A Prospective Randomized Controlled Study of Radiotherapy and the Concurrent Three-week and Single-week TP Chemotherapy for Advanced Cervical Squamous Cell Carcinoma and the Correlation Between HPV Classification and Sensitivity. | ||
NCT04998760 | A Study to Evaluate Dual mTORC1/2 Inhibitor (ATG 008) or Selective Inhibitor of Nuclear Export Compound (ATG-010) in Combination With Chemotherapy in Patients With Relapsed or Metastatic Ovarian Cancer, Endometrial Cancer, and Cervical Cancer ( PORCH ) | ||
NCT05147844 | Toripalimab Combined With Radiotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma | ||
NCT05780372 | Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma | ||
NCT05524168 | SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma | ||
NCT04276532 | Sentinel Lymph Node Sampling for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus | ||
NCT04638270 | Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL | ||
NCT04303247 | CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL | ||
NCT03373058 | Efficacy of HIPEC in the Treatment of Advanced-Stage Epithelial Ovarian Cancer After Cytoreductive Surgery | ||
NCT04370925 | Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis | ||
NCT04516551 | Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT | ||
NCT05356351 | An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer | ||
NCT05443672 | Multi-center Study of Deep Learning AI in Breast Mass | ||
NCT05788029 | Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas | ||
NCT05907447 | A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types | ||
NCT03716518 | Herbal Treatment to Improve Chemotherapy Delivery | ||
NCT03661671 | Application of Linked Color Imaging(LCI) in Diagnosis of Early Gastric Cancer(EGC) | ||
NCT05464875 | A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors | ||
NCT05461664 | Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA | ||
NCT05440357 | Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study | ||
NCT05594095 | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | ||
NCT05759572 | Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer | ||
NCT05759546 | PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer | ||
NCT05205200 | Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA) | ||
NCT05342792 | Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma | ||
NCT04516616 | Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer |